☆ 4.6 Letter

Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 201, Issue 1, Pages 162-167

Publisher

WILEY

DOI: 10.1111/bjh.18672

Keywords

frailty; isatuximab; myeloma; pomalidomide; real-world

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.